A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Официальное название

Patient Engagement in Using the Technology for Self-Tracking Medication Safety Events

Обзор

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.

Вмешательства

• Другое Educational Intervention
  Receive educational materials and resources
• Другое Electronic Health Record Review
  Ancillary studies
• Процедура Follow-Up
  Receive follow-up contact
• Другое Internet-Based Intervention
  Use self-monitoring platform
• Другое Interview
  Ancillary studies
• Другое Survey Administration
  Ancillary studies

Первичные конечные точки

• Self-reported system usability [Срок оценки: Up to 6 months]
• Perceived usefulness [Срок оценки: Up to 6 months]
• Ease of use [Срок оценки: Up to 6 months]
• Attitudes toward use [Срок оценки: Up to 6 months]
• Intention to use and continuous use of the system over time [Срок оценки: Up to 12 months]
• Self-reported patient engagement [Срок оценки: Up to 6 months]
• System usage over time [Срок оценки: Up to 12 months]
• Patient activation levels [Срок оценки: Up to 6 months]
• Medication self-management ability [Срок оценки: Up to 6 months]
• Symptom distress [Срок оценки: Up to 6 months]

Вторичные конечные точки (1)

• Self-tracked, structured medication safety events or concerns [Срок оценки: Up to 12 months]

Критерии участия

Критерии включения

• Participants are adult patients (aged 18 years or older)
• Diagnosed with lung, colorectal, breast, or prostate cancer
• Are currently receiving active cancer treatments
• Are self-managing one or more prescribed cancer medications
• Participants must have access to technology devices (smartphone, tablet, computer) to track their experiences or concerns about medication safety events, or their family members can help them access technology devices to track the events or concerns
• Speaks and reads English or has a support person (family member or friend) who can assist

Критерии исключения

• Can't access technology or do not use technology
• Do not have access to the internet
• Do not speak or read English
• Not permitted to participate by their health care providers

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Не применимо

Модель

Одна группа

Маскирование

Открытое

Основная цель

Организация здравоохранения

Центры проведения

США · 1 центр

• University of Michigan Comprehensive Cancer Center — Ann Arbor

Идентификаторы

NCT: NCT07291414 · UMCC 2025.050 · NCI-2025-08754 · HUM00272763 · R01HS027846

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗